Negative nasopharyngeal SARS-CoV-2 PCR conversion in Response to different therapeutic interventions
MH Shabrawishi et al, MEDRXIV, May 11, 2020
MH Shabrawishi et al, MEDRXIV, May 11, 2020
COVID-19 and Racial/Ethnic Disparities
MW Hooper et al, JAMA, May 11, 2020
MW Hooper et al, JAMA, May 11, 2020
A strategic approach to COVID-19 vaccine R&D
L Corey et al, Science, May 11, 2020
L Corey et al, Science, May 11, 2020
The full development pathway for an effective vaccine for SARS-CoV-2 will require that industry, government, and academia collaborate in unprecedented ways, each adding their individual strengths. We discuss one such collaborative program that has recently emerged: the ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) public-private partnership.
.png)
No hay comentarios:
Publicar un comentario